Active Ingredient: NALTREXONE
Proprietary Name: NALTREXONE
Dosage Form; Route of Administration: FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 380MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A213195
Product Number: 001
Approval Date: Jul 6, 2023
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
